White label ELPA - ClinicalTrials.eu

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Not recruiting

3 1
Investigated diseases:
- Skin ulcer
Investigated drugs:
- Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
+4
Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated diseases:
- Hodgkin’s disease recurrent
- Hodgkin’s disease refractory
Investigated drugs:
Study Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Secukinumab
Study on ITPP and Sodium Chloride for Patients with COVID-19 and Other Lung Infections Facing Breathing Problems

Not recruiting

2 1 1
Investigated diseases:
- COVID-19
Investigated drugs:
- Sodium Chloride
Study of Cenobamate for Children with Partial-Onset Seizures

Not recruiting

1 1 1
Investigated diseases:
- Partial seizures
Investigated drugs:
- Cenobamate
Long-Term Study on Oxytocin for Children with Prader-Willi Syndrome Up to Age 4

Not recruiting

2 1 1
Investigated diseases:
- Prader-Willi syndrome
Investigated drugs:
- Oxytocin
Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
+1
Title: Safety and effectiveness study of pegzilarginase weekly injections in children under 2 years old with Arginase 1 Deficiency

Not recruiting

3 1 1 1
Investigated diseases:
- Arginase deficiency
Investigated drugs:
- PEGZILARGINASE
Study on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses

Not recruiting

2 1 1
Investigated diseases:
- Secondary progressive multiple sclerosis
Investigated drugs:
- Cladribine
Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies